EUR-EONIA-OIS-COMPOUND definition

EUR-EONIA-OIS-COMPOUND means that the rate for a Reset Date, calculated in accordance with the formula set forth in Section 2A.7.4, will be the rate of return of a daily compound interest investment (it being understood that the reference rate for the calculation of interest is the arithmetic mean of the daily rates of the day-to-day Euro-zone interbank euro money market).
EUR-EONIA-OIS-COMPOUND means a rate calculated as follows (which, for the avoidance of doubt and as of the Issue Date, is equal to EuroSTR + 0.085%), and the resulting percentage will be rounded, if necessary, to the nearest one ten-thousand of a percentage point (0.0001%)(with 0.00005 being rounded up):
EUR-EONIA-OIS-COMPOUND means a rate calculated as follows, and the resulting percentage will be rounded, if necessary, to the nearest one ten-thousand of a percentage point (0.0001%)(with 0.00005 being rounded up):

Examples of EUR-EONIA-OIS-COMPOUND in a sentence

  • EUR-EONIA-OIS-COMPOUND has the meaning given to it in the ISDA 2000 Definitions or ISDA 2006 Definitions (as applicable) EUR-EONIA-OIS Compound has the meaning given to it in the ISDA 2021 Definitions.

  • The Benchmark Rate for each day in a Calculation Period occurring on or after an EONIA Index Cessation Effective Date will be determined as if references to EONIAi in the definition of EUR-EONIA-OIS-COMPOUND were references to Modified EuroSTRi.

  • Floating Rate Option: EUR-EONIA-OIS-COMPOUND, unless such rate (or component of such rate) cannot be determined for any day in an Interest Period, in which case the rate (or component of such rate) for that day will be determined by the Calculation Agent (acting in a commercially reasonable manner).

  • Where the Floating Rate Option is EUR-EONIA-OIS-COMPOUND, for the purposes of the ISDA Definitions, the “Calculation Period” shall be each relevant Interest Period.

  • In the event that the Maturity Date is extended beyond the Scheduled Maturity Date pursuant to the provisions of paragraph 8.1(ii) above, the Floating Rate Option in respect of the period from and including the Scheduled Maturity Date to but excluding the Maturity Date shall be EUR-EONIA-OIS-COMPOUND or (if the Deposit Bank is replaced as described in paragraph 22(ii) below) such other floating rate as is then applicable to the Deposit (as defined in paragraph 22(i) below).

  • Upon the occurrence of a EuroSTR Index Cessation Event, the Benchmark Rate for each day in a Calculation Period occurring on or after the EuroSTR Index Cessation Effective Date will be determined as if references to EONIAi in the definition of EUR-EONIA-OIS-COMPOUND were references to the ECB Recommended Ratei.

  • Floating Rate Option: EUR-EURIBOR-Reuters provided that in respect of the Interest Period commencing on the Scheduled Maturity Date or the Early Redemption Date, as the case may be, the Floating Rate Option will be EUR-EONIA-OIS-COMPOUND.

  • One copy of original Catalogues & manuals from Original OEM’s includes all the specifications & photos of every Items listed in Schedule B.

  • It has since been agreed that further expenditure would not represent good value for money though two large schemes were completed during 2007/08 and the final scheme – Percival Estate – will be completed in early 2008/09.


More Definitions of EUR-EONIA-OIS-COMPOUND

EUR-EONIA-OIS-COMPOUND means a reference rate equal to the overnight rate as calculated by the European Central Bank and appearing on Reuters Screen EONIA Page in respect of each day in the Interest Period;

Related to EUR-EONIA-OIS-COMPOUND

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Licensed Compound means [***].

  • Back-Up Compound means, with reference to any particular Development Candidate or Drug Product Candidate, a Compound which (a) has the same principal mode of action (i.e., Potentiator or Corrector) as that Development Candidate or Drug Product Candidate; and (b) was among the group of Compounds, identified by VERTEX as potential additional lead molecules having the same principal mode of action, from which the Development Candidate was selected.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Compound means the taking of two or more ingredients and fabricating them into a single

  • Biosimilar Product means, with respect to a Licensed Product in any country, any biosimilar product sold by a Third Party not authorized by or on behalf of Celgene, its Affiliates or Sublicensees, (a) that is a biosimilar biological product, as defined in 21 USC 379j-51 (or any successor or replacement thereof), a similar biological medicinal product, as defined in Annex I to Directive 2001/83/EC (or any successor or replacement thereof), or any similar biosimilar or generic product under the Laws of any country or jurisdiction, or (b) regarding which Regulatory Approval is obtained by referencing Regulatory Data of such Licensed Product.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • Combination Product means any product that comprises a Licensed Compound or Licensed Product sold in conjunction with another active component so as to be a combination product (whether packaged together or in the same therapeutic formulation).

  • Compounds means any or all of the following chemicals, as the context requires:

  • Collaboration Product means a pharmaceutical product containing or comprising Compound in any dosage form alone, or in combination with, one or more other pharmaceutically active ingredients, and any and all Improvements thereto.

  • Opioid antidote means any drug, regardless of dosage amount or method of administration, which has been approved by the United States Food and Drug Administration (FDA) for the treatment of an opioid overdose. “Opioid antidote” includes, but is not limited to, naloxone hydrochloride, in any dosage amount, which is administered through nasal spray or any other FDA-approved means or methods.

  • Therapeutically equivalent drug products means drug products that contain the same active

  • Milk product or "dairy product" means cottage cheese, dry curd cottage cheese, reduced fat cottage cheese, lowfat cottage cheese, cream, light cream, light whipping cream, heavy cream, heavy whipping cream, whipped cream, whipped light cream, sour cream, acidified sour cream, cultured sour cream, half-and-half, sour half-and-half, acidified sour half-and-half, cultured sour half-and-half, reconstituted or recombined milk and milk products, concentrated milk, concentrated milk products, skim milk, lowfat milk, frozen milk concentrate, flavored milk, eggnog, buttermilk, cultured milk, cultured lowfat milk, cultured skim milk, yogurt, lowfat yogurt, nonfat yogurt, acidified milk, acidified lowfat milk, acidified skim milk, low-sodium milk, low-sodium lowfat milk, low-sodium skim milk, lactose-reduced milk, lactose-reduced lowfat milk, lactose-reduced skim milk, aseptically processed and packaged milk, milk products with added safe and suitable microbial organisms, and any other milk product made by the addition or subtraction of milkfat or addition of safe and suitable optional ingredients for protein, vitamin, or mineral fortification. Unless a product is considered a milk product under this subdivision, milk product does not include dietary products, infant formula, ice cream or other desserts, cheese, or butter. Milk products include the following:

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Biological Samples means any physical samples obtained from Study Participants in accordance with the Protocol for the purposes of the Study.

  • Development Candidate means a Collaboration Compound designated by Biogen Idec as a Development Candidate in accordance with Section 2.6.

  • Exempt compound means the same as defined in Rule 2.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Licensed Product means a product, method or service in the Licensed Field of Use, the making, having made, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Antibody means a molecule or a gene encoding such a molecule comprising or containing one or more immunoglobulin variable domains or parts of such domains or any existing or future fragments, variants, modifications or derivatives thereof.

  • Edible cannabis product means cannabis product that is intended to be used, in whole or in part, for human consumption, including, but not limited to, chewing gum, but excluding products set forth in Division 15 (commencing with Section 32501) of the Food and Agricultural Code. An edible cannabis product is not considered food, as defined by Section 109935 of the Health and Safety Code, or a drug, as defined by Section 109925 of the Health and Safety Code.

  • Anti-Static Product means a product that is labeled to eliminate, prevent, or inhibit the accumulation of static electricity. “Anti-Static Product” does not include “Electronic Cleaner,” “Floor Polish or Wax,” “Floor Coating,” and products that meet the definition of “Aerosol Coating Product” or “Architectural Coating.”

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Combination Products means any product containing both a pharmaceutically active agent or ingredient which constitutes a Licensed Product and one or more other pharmaceutically active agents or ingredients which do not constitute Licensed Products.